Dr. Kurt R. Gehlsen

Dr. Kurt R. Gehlsen

Florida, USA

Vice President and Chief Scientific Officer Biorasi, Inc.

About Dr. Kurt R. Gehlsen

Dr. Gehlsen is the Vice President and Chief Scientific Officer (CSO) of Biorasi, Inc. and Head of the Medical and Scientific Affairs Group. Prior to Biorasi, Dr. Gehlsen was Vice President and CSO of Research Corporation Technologies (RCT), a early-stage investment and development firm in Tucson, AZ from 2005 to 2018. Dr. Gehlsen was Senior Vice President, Development and Chief Scientific Officer at Maxim Pharmaceuticals, a public San Diego biopharmaceutical company from 1996 to 2004 and developed CepleneTM as the first immune-oncology drug to be approved as a remission maintenance therapy for AML. Prior to Maxim, Dr. Gehlsen was founder and Chief Executive Officer of Trauma Products, a San Diego start-up company that developed and obtained approval of RescueFlowTM, a small volume resuscitation solution for life-threatening trauma with the US Army. He also was Director of Research and Head of Molecular and Cellular Biology, Experimental Medicine Division of Pharmacia, AB. Dr. Gehlsen was a Postdoctoral Fellow and Research Associate at the Burnham Institute and has held research positions as Associate Professor at the Sidney Kimmel Cancer Center in La Jolla, Associate Staff Scientist at the California Institute for Biological Research and as Founder, Vice President and Chief Operating Officer at the La Jolla Institute for Experimental Medicine.

Upcoming Conferences

CANCER SCIENCE & THERAPEUTICS 2020 “Webinar”
Cancer Science & Therapeutics 2020 "Webinar"
Theme: New Challenges in Cancer Treatment and Research During COVID-19 Pandemic
Virtual
October 3rd, 2020
Cancer Science & Therapeutics 2021
Cancer Science & Therapeutics 2021
Theme: Understanding Covid-19 & Cancer through Multidisciplinary Approach
Vancouver, Canada
April 15th - April 17th, 2021

MEET THE EXPERTS

Dr. Samer Hussein, Professeur adjoint, Département de Biologie Moléculaire, Biochimie Médicale et Pathologie. Université Laval
Samer Hussein, Ph.D.
Québec, Canada
Professeur adjoint, Département de Biologie Moléculaire, Biochimie Médicale et Pathologie
Dr. Donald Davidoff, Massachusetts, USA
Dr. Donald Davidoff, Massachusetts, USA
Massachusetts, United States
Chief, Department of Neuropsychology at McLean Hospital, Assistant Professor Harvard Medical School
Dr. Jean-Yves Masson Professor, Laval University Cancer Research Center, Quebec, Canada
Dr. Jean-Yves Masson
Quebec, Canada
Full Professor, Université Laval
Dr. Donna Hedges, Director, Nursing Services at Orbis Education, Texas, USA
Donna Hedges, PhD, MSN, MBA, CNE
Texas, USA
Director, Nursing Services at Orbis Education
Dr. Deborah M Leveille, Founder/Dean School of Nursing at Stawa University, Alabama, USA
Deborah M Leveille,PhD,RN,CNL
Alabama,USA
Dean of Nursing at Fortis College-Montgomery, National Nursing Curriculum Committee Chair
Adele Webb, PhD, RN, FNAP, FAAN
Ohio,USA
Executive Dean of Healthcare Initiatives at Capella University
Dr. Oliver J. Morgan, Pennsylvania , USA
Oliver J. Morgan, Ph.D., LMFT, MAC
Pennsylvania,USA
Professor Scranton, PA , Counseling & Human Services University of Scranton
Dr. Hank C. Hill, California, USA
Hank C. Hill, MD, Surgical Oncology
Florida, USA
Fellowship-Trained Surgical Oncologist Board Certified General Surgeon
Prof. Dr. Fusun Terzioglu, Ankara, Turkey
Prof.Dr. Fusun Terzioglu (RN, Msc, PhD) Atilim University
Ankara Province, Turkey
Dean of Faculty of Health Science, Ankara, Turkey
Hilal Arnouk, MD, PhD
Hilal Arnouk, MD, PhD
Chicago, USA
Assistant Professor at the Department of Pathology at Midwestern University
Dr. Reezena H. Malaska, Florida, USA
Dr. Reezena H. Malaska, DNP, MSN, RN, CCRN
Florida, USA
Critical Care Educator/Clinical Instructor/Professor
Dr. Myron R. Szewczuk Professor of Immunology, Dept. Biomedical & Molecular Sciences, Queen’s University
Myron R. Szewczuk, Ph.D.
Ontario, Canada
Professor of Immunology, Queen’s University, Kingston, Ontario, Canada

Submit Your E-Poster

CE Accreditation

This nursing continuing professional development activity was approved by Montana Nurses Association, an accredited approver with distinction by the American Nurses Credentialing Center’s Commission on Accreditation.

Download Brochure

Submit Your Abstract